Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Collectively, the deals reposition vaccines as long-horizon disease-modifying infrastructure, leveraging epidemiologic and mechanistic links between infections (eg, VZV, EBV) and neurodegeneration, ...

Procurement frameworks now incorporate resilience criteria, enabling tender preference for diversified, Europe-based manufacturing and contingency capacity over lowest price, reshaping economics for ...

Precision for Medicine, explains why radiopharmaceuticals are unique for patients with cancer and what makes them challenging ...

Dr. Christine Allen, Co-Founder and CEO of Intrepid Labs, and Dr. Andrew Lewis, Chief Scientific Officer of Quotient Sciences, explain how AI can be used in drug development to shorten development ...

Tracy Beth Høeg said she was fired; Katherine Szarama departs as acting CBER director but remains at FDA, signaling rapid ...

Bristol Myers Squibb collaborates with Anthropic to accelerate drug development, manufacturing quality systems, and regulatory documentation via AI integration. Bristol Myers Squibb (BMS) has ...

Building resilient, adaptable operations capable of evolving alongside the rapid transformation of the biologics industry is key for downstream processing.

Upstream titers of 3–5 g/L, and up to 10–13 g/L, are outpacing downstream capacity, creating chromatography, filtration, and UF/DF throughput bottlenecks that elevate cost and delay timelines. Complex ...

Understand how Piramal leads the CDMO market in delivering well-constructed and well-executed integrated services. Learn why programs need to consider both drug substance and drug product from the ...